Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Ischemic and Bleeding Risk In Patients On Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: An Individualized Patient Centered Machine Learning Model

NCT06089304 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT06089304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06089304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Ischemic and Bleeding Risk In Patients On Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: An Individualized Patient Centered Machine Learning Model
Lead sponsor
Abbott Medical Devices
Phase
Observational
Overall status
Completed
Start date
May 31, 2008
Completion date
October 31, 2023
Enrollment
19,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, percutaneous coronary intervention